D.E. Shaw & Co
AGTC

D.E. Shaw & Co’s Applied Genetic Technologies Corporation AGTC Stock Holding History

D.E. Shaw & Co’s Portfolio AGTC Stock Details AGTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-54,702
Closed -$228K – 4236
2019
Q3 		$228K Sell
54,702
-3,200
-6% -$11.6K ﹤0.01% 3581
2019
Q2 		$219K Buy
57,902
+10,329
+22% +$42.3K ﹤0.01% 3438
2019
Q1 		$199K Buy
47,573
+21,040
+79% +$73.5K ﹤0.01% 3407
2018
Q4 		$66K Sell
26,533
-28,087
-51% -$165K ﹤0.01% 3670
2018
Q3 		$399K Buy
54,620
+22,560
+70% +$98.8K ﹤0.01% 3228
2018
Q2 		$119K Buy
32,060
+17,758
+124% +$82.2K ﹤0.01% 3600
2018
Q1 		$55K Sell
14,302
-1,688
-11% -$7.09K ﹤0.01% 3420
2017
Q4 		$58K Buy
+15,990
New +$60.4K ﹤0.01% 3528
2017
Q1 		– Sell
-11,085
Closed -$104K – 3681
2016
Q4 		$104K Sell
11,085
-1,012
-8% -$9.12K ﹤0.01% 3343
2016
Q3 		$118K Sell
12,097
-16,447
-58% -$222K ﹤0.01% 3273
2016
Q2 		$403K Sell
28,544
-39,200
-58% -$612K ﹤0.01% 2885
2016
Q1 		$947K Buy
67,744
+44,561
+192% +$654K ﹤0.01% 2392
2015
Q4 		$473K Buy
+23,183
New +$358K ﹤0.01% 3121

Other funds holding AGTC

IVM
InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $524M AUM 164.42% 1-Year Est. Return
AGA
Altrinsic Global Advisors Stamford, Connecticut $2.72B AUM 7.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

D.E. Shaw & Co's AGTC Position: Q4 2019 in Review

D.E. Shaw & Co sold out of Applied Genetic Technologies Corporation (AGTC) in Q4 2019, closing a stake of 54,702 shares — an estimated $228K sold.

D.E. Shaw & Co first reported a position in AGTC in Q4 2015 and held it in 13 quarters. The position peaked at $947K in Q1 2016. 52 funds tracked by Wall St. Rank hold AGTC as of Q4 2019.

  • D.E. Shaw & Co reported no remaining Applied Genetic Technologies Corporation position as of Q4 2019 after selling out during the quarter.
  • D.E. Shaw & Co sold 54,702 Applied Genetic Technologies Corporation shares in Q4 2019, an estimated $228K.
  • D.E. Shaw & Co first reported a position in Applied Genetic Technologies Corporation in Q4 2015 and held it in 13 quarters.
  • D.E. Shaw & Co's Applied Genetic Technologies Corporation position peaked at $947K in Q1 2016.
  • 52 funds tracked by Wall St. Rank held Applied Genetic Technologies Corporation as of Q4 2019.

Based on D.E. Shaw & Co's 13F filing for Q4 2019, filed 14 Feb 2020.